New nasal spray aims to calm social anxiety during public speaking

NCT ID NCT06809179

Recruiting now Symptom relief Sponsor: VistaGen Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 31 times

Summary

This study tests a nasal spray called fasedienol (PH94B) for quickly reducing anxiety during a public speaking task in adults with social anxiety disorder. About 60 participants will receive either the spray or a placebo and rate their distress levels. The goal is to see if the spray is safe and effective for on-the-spot anxiety relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Vistagen Clinical Site
RECRUITING

Sherman Oaks, California, 91403, United States
Vistagen Clinical Site
RECRUITING

Walnut Creek, California, 94596, United States
Vistagen Clinical Site
RECRUITING

Largo, Florida, 33777, United States
Vistagen Clinical Site
RECRUITING

Saint Charles, Missouri, 63304, United States
Vistagen Clinical Site
RECRUITING

Toms River, New Jersey, 08755, United States
Vistagen Clinical Site
RECRUITING

Cary, North Carolina, 27511, United States
Vistagen Clinical Site
TERMINATED

Cleveland, Ohio, 44130, United States
Vistagen Clinical Site
RECRUITING

Plymouth Meeting, Pennsylvania, 19462, United States
Vistagen Clinical Site
TERMINATED

Plano, Texas, 75093, United States

Conditions

Explore the condition pages connected to this study.

SOCIAL ANXIETY DISORDER